Tectora Therapeutics

Tectora Therapeutics is a biotechnology company co-founded by Schrödinger; it closed a $55 million Series A investment led by NEA and RA Capital to advance immunology and inflammation programs. Distinct from the unrelated Johns Hopkins oncology spinout Terebra Therapeutics.